- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02041156
Effects of Different Exercise Training Programs in CKD 4-5 (RENEXC)
September 22, 2016 updated by: Region Skane
Long-term Effects of Basic Aerobic Training Combined With Either Resistance - or Balance Training in CKD Patients - a Comparative Study
The investigators' purpose is to study which exercise training modality: aerobic physical activity in conjunction with either resistance training or balance training, is most beneficial in patients with chronic kidney disease (CKD 4-5: GFR < 30 ml/min/1.73mUP[2]).
Furthermore, our purpose is to evaluate the long-term effects of exercise training on functional status, cardiovascular morbidity, blood pressure control, heart rate variability, cardiac function, inflammation, body composition, nutritional status, progression of uraemia and health related quality of life.
This interventional study is prospective, randomized and controlled comprising 150 prevalent and incident patients from our outpatient clinic.
Patients are invited to participate in the study consecutively, irrespective of basic functional status.
At start patients are randomised either to resistance or balance training and the programme is adapted and individualised to each patient's actual physical status and ability.
The exercise prescription is to exercise for 30 minutes/day, 5 days/week, keeping the intensity constant at a level of "somewhat strenuous" to "strenuous" on the Borg scale rate of perceived exertion.
The total observation period is 12 months with checks every four months.
Although exercise training is a recommended therapy in CKD, there is a lack of medical and scientific evidence on optimal prescription.
We hope that this study will provide evidence-based knowledge on exercise prescription and its effects on various risk factors in CKD patients.
Finally, if patients achieve a higher degree of physical functional capacity they should be able to maintain an autonomous lifestyle, resulting in considerable reductions in societal costs for care and transportation.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
150
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lund, Sweden, 221 85
- Recruiting
- Skane University Hospital
-
Contact:
- Matthias Hellberg, MD
- Phone Number: +4646175886
- Email: Matthias.Hellberg@skane.se
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- CKD 4 and 5
- over 18 years of age
- no neurological or orthopedic impairments
- stable cardiac status
Exclusion Criteria:
- not on renal replacement therapy
- no severe electrolyte disturbances
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: aerobic with resistance training
Regular aerobic activity combined with 3 sessions/week of resistance training totalling 150 minutes per week of physical activity
|
|
|
Active Comparator: aerobic with balance training
Regular aerobic activity combined with 3 sessions/week of balance training totalling 150 minutes per week of physical activity
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical function
Time Frame: 4, 8 and 12 months
|
6 minutes walking test, 30 seconds sit to stand, stair climbing, handgrip strength, Isometric quadriceps strength, functional reach, standing heel rise, toes lift, picking-up test, Berg balance scale
|
4, 8 and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Cardiovascular morbidity
Time Frame: after 12 months
|
after 12 months
|
|
Body composition
Time Frame: after 12 months
|
after 12 months
|
|
Quality of Life
Time Frame: 4,8 and 12 months
|
4,8 and 12 months
|
|
Inflammatory activity
Time Frame: 4, 8 and 12 months
|
4, 8 and 12 months
|
|
Bone density
Time Frame: 12 months
|
12 months
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Compliance to exercise training protocol
Time Frame: 4, 8 and 12 month
|
4, 8 and 12 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Naomi Clyne, MD, PhD, Lund University
- Principal Investigator: Matthias Hellberg, MD, Lund University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Zhou Y, Hellberg M, Hellmark T, Hoglund P, Clyne N. Twelve months of exercise training did not halt abdominal aortic calcification in patients with CKD - a sub-study of RENEXC-a randomized controlled trial. BMC Nephrol. 2020 Jun 22;21(1):233. doi: 10.1186/s12882-020-01881-y.
- Zhou Y, Hellberg M, Hellmark T, Hoglund P, Clyne N. Muscle mass and plasma myostatin after exercise training: a substudy of Renal Exercise (RENEXC)-a randomized controlled trial. Nephrol Dial Transplant. 2021 Jan 1;36(1):95-103. doi: 10.1093/ndt/gfz210.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2011
Primary Completion (Anticipated)
February 1, 2017
Study Completion (Anticipated)
February 1, 2017
Study Registration Dates
First Submitted
January 7, 2014
First Submitted That Met QC Criteria
January 17, 2014
First Posted (Estimate)
January 20, 2014
Study Record Updates
Last Update Posted (Estimate)
September 23, 2016
Last Update Submitted That Met QC Criteria
September 22, 2016
Last Verified
September 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2011:369
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.